Use of 3-D imaging on patients with pancreatic carcinoma

December 21, 2009

In the field of hepatic imaging in the context of living liver donors and before complex partial liver resections, three-dimensional imaging of the liver, hepatic vessels and bile ducts has managed to become established in some centers. In this case, in addition to visualization, the volumetry of various liver sections is of interest. Moreover, the three-dimensional reconstruction can be used preoperatively to consider various resection options and to evaluate their technical feasibility with regard to vascular and bile duct anatomy and to the expected liver volume after surgery.

A research article to be published on December 14, 2009 in the World Journal of Gastroenterology applies this method to the pancreas in patients with pancreatic carcinoma. The research team, led by Professor Grenacher from the University of Heidelberg, Department of Diagnostic and Interventional Radiology, found that a three-dimensional image of the pancreas represents an additional, valuable aid to the surgeon in the preoperative assessment of the resection of a pancreatic carcinoma. They examined ten patients with suspected pancreatic tumors prospectively using multidetector CT (Somatom Sensation 16, Siemens, Erlangen, Germany). Using the CT data sets, a three-dimensional image was created. The CT examinations and the three-dimensional images were presented to the surgeon directly before and during the operation. Immediately after surgery, the value of the two images was judged by the surgeon. In comparison to the CT image with axial and coronal reconstructions, the three-dimensional image was judged by the surgeons as better for operation planning and consistently described as useful. However, this method is time-consuming. The software must be further developed to allow further automation of the segmentation to enable it to be integrated into daily clinical routine.
-end-
Reference: Klauß M, Schöbinger M, Wolf I, Werner J, Meinzer HP, Kauczor HU, Grenacher L. Value of three-dimensional reconstructions in pancreatic carcinoma using multidetector CT: Initial results. World J Gastroenterol 2009; 15(46): 5827-5832 http://www.wjgnet.com/1007-9327/15/5827.asp

Correspondence to: Dr. Lars Grenacher, Professor, Department of Diagnostic and Interventional Radiology, University of Heidelberg, INF 110, Heidelberg 69120, Germany. lars.grenacher@med.uni-heidelberg.de
Telephone: +49-6221-5639758 Fax: +49-6221-565730

World Journal of Gastroenterology

Related Liver Articles from Brightsurf:

Eating less suppresses liver cancer due to fatty liver
Liver cancer from too much fat accumulation in the liver has been increasing in many countries including Japan.

When liver cirrhosis is deadly
A study by an international team of researchers headed by Professor Jonel Trebicka from the Frankfurt University Hospital and funded by the foundation EF Clif, has discovered which patients are particularly at risk for acute-on-chronic liver failure.

Fatty liver disease is underdiagnosed in the US
According to an analysis published in Alimentary Pharmacology & Therapeutics, nonalcoholic fatty liver disease (NAFLD) is grossly underdiagnosed in the United States.

A new treatment for liver cancer
In the latest issue of Molecular Therapy, Skoltech and MIT researchers have published a new combinatorial therapy for the treatment of liver cancer.

Longevity protein SIRT6 also protects against fatty liver and fatty liver disease
SIRT6 regulates fat metabolism by activating another protein called peroxisome proliferator-activated receptor alpha (PPAR-alpha).

Immune cell identity crisis: What makes a liver macrophage a liver macrophage?
UC San Diego researchers investigated how a type of immune cell called a macrophage becomes specialized to the liver.

Liver transplants could be redundant with discovery of new liver cell
Researchers at King's College London have used single cell RNA sequencing to identify a type of cell that may be able to regenerate liver tissue, treating liver failure without the need for transplants.

How viable is your liver after you die?
In a paper to be published in a forthcoming issue of TECHNOLOGY, a group of researchers from Harvard Medical School have done a study on the viability of donated livers and its correlation with donor demographics.

Blocking platelets: A possible option to prevent fatty liver disease and liver cancer
Blood platelets which interact with liver cells and immune cells play a major role in the development of fatty liver disease, non-alcoholic fatty liver inflammation and liver cancer, scientists from the German Cancer Research Center (DKFZ) in Heidelberg and from Zurich University and University Hospital have now shown in a publication.

Micro-control of liver metabolism
A new discovery has shed light on small RNAs called microRNAs in the liver that regulate fat and glucose metabolism.

Read More: Liver News and Liver Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.